Skip to content

Urgent urology symptoms What to do

Issues seen with drugs to curb prostate cancer: FDA

Urology TodayPublished November 29, 20102 min read

Key points

  • U.S. regulatory staff have raised concerns about data for two drugs by GlaxoSmithKline Plc and Merck & Co Inc and their effect on reducing the risk of prostate cancer in certain men.
  • Food and Drug Administration staff, in documents released ahead of a public advisory meeting on Wednesday, said overall, large trials for each of the drugs showed benefits after four years with Avodart and seven years with Merck’s drug, Proscar—mostly in men with certain grades of the cancer.
  • For Glaxo’s Avodart, advisers also cited concerns about use of biopsies and the impact of the drug on black men, among other issues.
  • “The benefit of finasteride for the risk reduction in prostate cancer is uncertain since the observed risk reduction of prostate cancer was present only in the subgroup of participants diagnosed” with certain tumors, FDA staff wrote.

U.S. regulatory staff have raised concerns about data for two drugs by GlaxoSmithKline Plc and Merck & Co Inc and their effect on reducing the risk of prostate cancer in certain men.

Both drugs are already approved to treat symptoms in men with enlarged prostate, but GlaxoSmithKline Plc is seeking a wider approval to market its drug, Avodart, as a way to curb the chances of prostate cancer in men who are at greater risk of developing the disease.

Food and Drug Administration staff, in documents released ahead of a public advisory meeting on Wednesday, said overall, large trials for each of the drugs showed benefits after four years with Avodart and seven years with Merck’s drug, Proscar—mostly in men with certain grades of the cancer.

They noted that “neither trial was adequately designed and conducted to characterize the ultimate outcomes of interest,” such as death. “In both trials, there was also an unexpected finding of an increased incidence of high-risk prostate cancers among men receiving” the drugs, they added.”

For Glaxo’s Avodart, advisers also cited concerns about use of biopsies and the impact of the drug on black men, among other issues.

Separately, advisers will also consider whether the new data should be included on the Proscar’s label, although Merck is not seeking formal approval for wider use. Proscar is also known by its chemical name finasteride.

“The benefit of finasteride for the risk reduction in prostate cancer is uncertain since the observed risk reduction of prostate cancer was present only in the subgroup of participants diagnosed” with certain tumors, FDA staff wrote.

At the meeting, an FDA panel of outside experts will weigh both companies’ data before offering the agency its recommendation. The FDA will later make the final decisions.

Glaxo’s shares were down 1.5 percent at $38.81 and Merck’s shares fell about 1 percent to $34.51, both in early trading on the New York Stock Exchange.

###
(Reuters)

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. If you cannot pass urine, have a fever with back or side pain, or sudden severe pain in the testicle, call 911 or go to an emergency department.

Urinary symptoms?

Weak stream, urgency, up at night? Score it in two minutes.

Seven questions from the International Prostate Symptom Score show whether symptoms are mild, moderate or severe, and when to see a doctor.

Take the symptom score

When to get help

Most urology problems can wait for an appointment. These can’t.

Call 911 or go to an emergency department if you have any of these:

  • You cannot pass urine at allAcute urinary retention: a painful, swollen bladder. It needs a catheter, often within hours.
  • Fever or chills with back or side painA blocked, infected kidney (for example behind a stone) can turn into sepsis quickly.
  • Sudden, severe pain in a testiclePossible testicular torsion. The testicle can often be saved only within about 6 hours.
  • An erection lasting over 4 hoursPriapism. Without treatment it can cause permanent damage.
Call 911

Outside the US, call your local emergency number.

See a doctor within days

  1. 01Blood in your urineEven once, and even without pain. Usually harmless, but it is the most common first sign of bladder and kidney cancer.
  2. 02Burning, frequent or cloudy urineTypical of a urinary tract infection, which usually clears with treatment.
  3. 03A lump or swelling in a testicleMost lumps are benign; testicular cancer is very treatable when found early.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.